Breaking News Instant updates and real-time market news.

DOVA

Dova Pharmaceuticals

$12.26

1.7 (16.10%)

12:21
06/27/19
06/27
12:21
06/27/19
12:21

Dova Pharmaceuticals price target increased to $39 from $18 at H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Dova Pharmaceuticals and raised his price target on shares to $39 from $18 after the FDA approved the company's expansion of Doptelet clinical use in chronic immune thrombocytopenia, or cITP, in the U.S. The analyst noted that the convenient dosing for Doptelet, the lack of hepatotoxicity, and the potential pricing advantage "could be seen as helpful footing to adoption and increased patient compliance," and added that he sees, considering the safety profile of the drug, an increasing market potential for Doptelet in cITP subjects with decompensated liver function.

  • 27

    Jun

  • 30

    Jun

DOVA Dova Pharmaceuticals
$12.26

1.7 (16.10%)

06/27/19
JPMS
06/27/19
NO CHANGE
JPMS
Underweight
JPMorgan keeps Underweight on Dova after supplemental Doptelet approval
JPMorgan analyst Anupam Rama keeps an Underweight rating on shares of Dova Pharmaceuticals after the FDA approved a supplemental New Drug Application that expands the use of Doptelet to include the treatment of thrombocytopenia in adults with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. It will take time to educate physicians on the differentiation points with respect to Doptelet, Rama tells investors in a research note. Further, given the disappointing launch in chronic liver disease, the analyst believes strong metrics will be need to be seen before investors gain confidence in the overall launch. He believes this will could take time. Shares of Dova Pharmaceuticals are up 17% to $12.35 in early trading.
06/25/19
HCWC
06/25/19
NO CHANGE
Target $18
HCWC
Buy
H.C. Wainwright says Dova EU approval as expected ahead of U.S. PDUFA for ITP
Dova Pharmaceuticals, as expected, announced that the European Commission approved the marketing of Doptelet for severe thrombocytopenia in adult patients with chronic liver disease, noted H.C. Wainwright analyst Joseph Pantginis. The analyst also noted that the U.S. PDUFA date for Doptelet in chronic ITP is June 30, though he believes that the FDA may act this coming Friday. Pantginis keeps a Buy rating on Dova shares with an $18 price target.
05/23/19
05/23/19
INITIATION
Target $19

Outperform
Wedbush bullish on Dova Pharmaceuticals, initiates with an Outperform
As previously reported, Wedbush analyst Laura Chico started coverage of Dova Pharmaceuticals with an Outperform and a $19 price target. Although the company's Doptelet now enters its second year on the market, the analyst believes that in many ways it is still just getting started as it has gained a new CEO, Chief Commercial Officer and marketing message. Her proprietary physician survey suggests increasing utilization by hepatologists is still to come. Moreover, the recent partnership with Salix Pharmaceuticals can facilitate expanding the Doptelet footprint more broadly into the gastroenterology space, she contends.
05/22/19
WEDB
05/22/19
INITIATION
Target $19
WEDB
Outperform
Dova Pharmaceuticals initiated with an Outperform at Wedbush
Wedbush analyst Laura Chico started Dova Pharmaceuticals with an Outperform rating and $19 price target.

TODAY'S FREE FLY STORIES

CNK

Cinemark

$36.46

-1.31 (-3.47%)

06:57
07/19/19
07/19
06:57
07/19/19
06:57
Initiation
Cinemark initiated  »

Cinemark initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXT

Sensient

$70.77

-0.48 (-0.67%)

06:56
07/19/19
07/19
06:56
07/19/19
06:56
Earnings
Sensient reports Q2 EPS 81c, consensus 82c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

EYE

National Vision

$32.05

0.35 (1.10%)

06:56
07/19/19
07/19
06:56
07/19/19
06:56
Hot Stocks
National Vision names Melissa Rasmussen as Chief Accounting Officer »

National Vision announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

06:55
07/19/19
07/19
06:55
07/19/19
06:55
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDFN

Redfin

$16.84

-0.74 (-4.21%)

06:54
07/19/19
07/19
06:54
07/19/19
06:54
Initiation
Redfin initiated  »

Redfin initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

LYB

LyondellBasell

$85.70

-0.03 (-0.03%)

06:52
07/19/19
07/19
06:52
07/19/19
06:52
Initiation
LyondellBasell initiated  »

LyondellBasell reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Z

Zillow

$48.20

0.08 (0.17%)

06:51
07/19/19
07/19
06:51
07/19/19
06:51
Initiation
Zillow initiated  »

Zillow initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:49
07/19/19
07/19
06:49
07/19/19
06:49
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

BLK

BlackRock

$474.98

4.06 (0.86%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Hot Stocks
BlackRock CEO: People are underinvested in equities »

Says: Markets will trend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

ATHM

Autohome

$82.03

-0.91 (-1.10%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Downgrade
Autohome rating change  »

Autohome downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$38.78

0.15 (0.39%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Hot Stocks
Schlumberger names Olivier Le Peuch as CEO, succeeding Paal Kibsgaard »

Schlumberger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

NWSA

News Corp.

$13.28

0.06 (0.45%)

06:47
07/19/19
07/19
06:47
07/19/19
06:47
Downgrade
News Corp. rating change  »

JPMorgan downgrades News…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$38.78

0.15 (0.39%)

06:46
07/19/19
07/19
06:46
07/19/19
06:46
Hot Stocks
Breaking Hot Stocks news story on Schlumberger »

Schlumberger names…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

MSGN

MSG Networks

$20.22

-0.31 (-1.51%)

06:43
07/19/19
07/19
06:43
07/19/19
06:43
Downgrade
MSG Networks rating change  »

MSG Networks downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

06:39
07/19/19
07/19
06:39
07/19/19
06:39
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$34.62

0.27 (0.79%)

06:39
07/19/19
07/19
06:39
07/19/19
06:39
Hot Stocks
Citizens Financial increases dividend 13% to 36c per share »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:38
07/19/19
07/19
06:38
07/19/19
06:38
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CFG

Citizens Financial

$34.62

0.27 (0.79%)

06:36
07/19/19
07/19
06:36
07/19/19
06:36
Earnings
Citizens Financial reports Q2 EPS 96c, consensus 94c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

TSLA

Tesla

$253.82

-1.03 (-0.40%)

06:35
07/19/19
07/19
06:35
07/19/19
06:35
Recommendations
Tesla analyst commentary  »

Barclays forecasts much…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

, PANW

Palo Alto Networks

$222.31

-1.34 (-0.60%)

06:28
07/19/19
07/19
06:28
07/19/19
06:28
Recommendations
Crowdstrike, Palo Alto Networks analyst commentary  »

Crowdstrike price target…

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

PANW

Palo Alto Networks

$222.31

-1.34 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALT

Altimmune

$2.34

-0.1 (-4.10%)

06:25
07/19/19
07/19
06:25
07/19/19
06:25
Initiation
Altimmune initiated  »

Altimmune initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$206.26

2.14 (1.05%)

06:23
07/19/19
07/19
06:23
07/19/19
06:23
Hot Stocks
CME Group subsidiary completes first cleared inflation swap compression run »

TriOptima announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

ETFC

E-Trade

$46.50

0.78 (1.71%)

06:23
07/19/19
07/19
06:23
07/19/19
06:23
Recommendations
E-Trade analyst commentary  »

E-Trade price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

ALV

Autoliv

$69.88

0.04 (0.06%)

06:23
07/19/19
07/19
06:23
07/19/19
06:23
Earnings
Breaking Earnings news story on Autoliv »

Autoliv sees lower FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:22
07/19/19
07/19
06:22
07/19/19
06:22
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.